New Treatment Approved for Adults and Children With Pompe Disease

被引:0
|
作者
Kuehn, Bridget M.
机构
来源
关键词
D O I
10.1001/jama.2021.15589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1000 / 1000
页数:1
相关论文
共 50 条
  • [21] Clinical benefit of treatment with alglucosidase alfa in infants and children with advanced Pompe disease
    Nicolino, M.
    Byrne, B.
    Spencer, C.
    Levine, J.
    Leslie, N.
    Wraith, E.
    Kishnani, P.
    CLINICAL THERAPEUTICS, 2008, 30 : S33 - S33
  • [22] The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease
    Truninger, Moritz Ilan
    Werner, Helene
    Landolt, Markus Andreas
    Hahn, Andreas
    Hennermann, Julia B.
    Lagler, Florian B.
    Moeslinger, Dorothea
    Pfrimmer, Charlotte
    Rohrbach, Marianne
    Huemer, Martina
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (06) : 1348 - 1362
  • [23] A review of treatment of Pompe disease in infants
    Chien, Yin-Hsiu
    Hwu, Wuh-Liang
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (03): : 195 - 201
  • [24] Pharmacological chaperone treatment for Pompe disease
    Do, Hung
    Flanagan, John
    Wu, Xiaoyang
    Powe, Allan
    Khana, Richie
    Soska, Rebecca
    Liang, Wei
    Benjamin, Elfrida
    Palling, David
    Sitaraman, Sheela
    Wustman, Brandon
    Valenzano, Ken
    Lockhart, David
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S19 - S19
  • [25] Immunological Aspects of Treatment of Pompe Disease
    Kishnani, Priya S.
    CLINICAL THERAPEUTICS, 2010, 32 : S49 - S50
  • [26] Molecular Approaches for the Treatment of Pompe Disease
    Anita Sofia Bellotti
    Luca Andreoli
    Dario Ronchi
    Nereo Bresolin
    Giacomo P. Comi
    Stefania Corti
    Molecular Neurobiology, 2020, 57 : 1259 - 1280
  • [27] Survival and Prognostic Factors Prior to Enzyme Replacement Therapy in 302 Children and Adults with Pompe Disease
    Gungor, Deniz
    de Vries, Juna M.
    Hop, Wim C. J.
    Reuser, Arnold J. J.
    van Doorn, Pieter A.
    van der Ploeg, Ans T.
    Hagemans, Marloes L. C.
    CLINICAL THERAPEUTICS, 2011, 33 : S11 - S11
  • [28] Immunological aspects of treatment of Pompe disease
    Kishnani, Priya
    Banugaria, Suhrad
    DeArmey, Stephanie
    Mackey, Joanne
    Young, Sarah
    Bali, Deeksha
    Koeberl, Dwight
    Rosenberg, Amy
    Messinger, Yoav
    Mendelsohn, Nancy S.
    Rhead, William
    Chen, Y. T.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S23 - S23
  • [29] Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
    Ditters, Imke A. M.
    van der Beek, Nadine A. M. E.
    Brusse, Esther
    van der Ploeg, Ans T.
    van den Hout, Johanna M. P.
    Huidekoper, Hidde H.
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [30] Molecular Approaches for the Treatment of Pompe Disease
    Bellotti, Anita Sofia
    Andreoli, Luca
    Ronchi, Dario
    Bresolin, Nereo
    Comi, Giacomo P.
    Corti, Stefania
    MOLECULAR NEUROBIOLOGY, 2020, 57 (02) : 1259 - 1280